Browsing by Author "Oaknin benzaquen, Ana Mazaltob"
Now showing items 1-20 of 23
-
A phase I dose-finding, pharmacokinetics and genotyping study of olaparib and lurbinectedin in patients with advanced solid tumors
Poveda, Andres; Oaknin benzaquen, Ana Mazaltob; Romero, Ignacio; Guerrero‑Zotano, Angel; Fariñas Madrid, Lorena; Rodriguez‑Freixinos, Victor (Nature Research, 2021-02-24) -
Clinical research disruption in the post-COVID-19 era: will the pandemic lead to change?
Lorusso, Domenica; Ray-Coquard, Isabelle; Oaknin benzaquen, Ana Mazaltob; Banerjee, Susana (BMJ, 2020-10-13) -
Evolving Landscape of Molecular Prescreening Strategies for Oncology Early Clinical Trials
Dienstmann, Rodrigo; Garralda Cabanas, Elena; Aguilar, Susana; Sala De Vedruna, Gemma; Viaplana Donato, Cristina; Ruiz Pace, Fiorella; González-Zorelle, Jenifer; Grazia LoGiacco, Deborah; Ogbah, Zighereda; Ramos Masdeu, Laia; Mancuso, Francesco Mattia; Fasani, Roberta; Jiménez Flores, José Antonio; Martinez, Paola; Oaknin benzaquen, Ana Mazaltob; Saura Manich, Cristina; Antunes de Melo Oliveira, Ana Mafalda; Balmaña Gelpí, Judith; Carles Galceran, Joan; Macarulla Mercadé, Teresa; Elez Fernandez, Mª Elena; Alsina Maqueda, Maria; Braña Garcia, Irene; Felip Font, Enriqueta; Tabernero Caturla, Josep; Rodon Ahnert, Jordi; Nuciforo, Paolo Giovanni; Vivancos Prellezo, Ana (American Society of Clinical Oncology, 2020-05-14) -
First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion
Banerjee, Susana; Gonzalez-Martin, Antonio; Harter, Philipp; Lorusso, Domenica; Moore, Kathleen N; Oaknin benzaquen, Ana Mazaltob (BMJ, 2020-12-11) -
Genomic heterogeneity and efficacy of PI3K pathway inhibitors in patients with gynaecological cancer
Rodriguez Freixinos, Victor; Ruiz Pace, Fiorella; Fariñas Madrid, Lorena; Garrido-Castro, Ana Christina; Villacampa Javierre, Guillermo; Nuciforo, Paolo Giovanni; Vivancos Prellezo, Ana; Dienstmann, Rodrigo; Oaknin benzaquen, Ana Mazaltob (BMJ, 2019-03-08) -
ICO-ICS Praxi per al tractament mèdic del càncer epitelial d'ovari
Barretina-Ginesta, Maria-Pilar; Carreras Soler, Maria Josep; Gil Martín, Marta; Guerra-Prió, Silvia; Lezcano-Rubio, Clara; Mangues-Bafalluy, Irene; Pardo, Beatriz; Piulats, Josep M.; Oaknin benzaquen, Ana Mazaltob; Recalde-Penabad, Sabela; Romeo-Marín, Marga; Rey-Salido, Montserrat (Institut Català de la SalutInstitut Català d'Oncologia, 2017-11) -
Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer
Makker, Vicky; Taylor, Matthew H.; Aghajanian, Carol; Oaknin benzaquen, Ana Mazaltob; Mier, James; Cohn, Allen L. (American Society of Clinical Oncology, 2020-09-10) -
Maintenance treatment with rucaparib for recurrent ovarian carcinoma in ARIEL3, a randomized phase 3 trial: The effects of best response to last platinum-based regimen and disease at baseline on efficacy and safety
Oaknin benzaquen, Ana Mazaltob; Oza, Amit M.; Lorusso, Domenica; Aghajanian, Carol; Dean, Andrew; Colombo, Nicoletta (Wiley, 2021-10) -
Management of advanced ovarian cancer in Spain: an expert Delphi consensus
Redondo Sanchez, Andres; Oaknin benzaquen, Ana Mazaltob; Rubio, Maria Jesus; Barretina-Ginesta, Maria-Pilar; de Juan Ferre, Ana; Manso, Luis (BMC, 2021-05-26) -
Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2)
Swisher, Elizabeth M.; Kwan, Tanya T.; Oza, Amit M.; Tinker, Anna V.; Ray-Coquard, Isabelle; Oaknin benzaquen, Ana Mazaltob (Nature Research, 2021-05-03) -
Neratinib in patients with HER2 -mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial
Oaknin benzaquen, Ana Mazaltob; Friedman, Claire F.; Roman, Lynda D.; D'Souza, Anishka; Braña Garcia, Irene; Bidard, François-Clement (Elsevier, 2020-10) -
Olaparib in combination with pegylated liposomal doxorubicin for platinum-resistant ovarian cancer regardless of BRCA status: a GEICO phase II trial (ROLANDO study)
Perez-Fidalgo, J. A.; Cortés, A.; Guerra, Eva; García, Y.; Iglesias, M.; Bohn Sarmiento, U.; Oaknin benzaquen, Ana Mazaltob (Elsevier, 2021-08) -
Patient-Centered Outcomes in ARIEL3, a Phase III, Randomized, Placebo-Controlled Trial of Rucaparib Maintenance Treatment in Patients With Recurrent Ovarian Carcinoma
Oza, Amit M.; Lorusso, Domenica; Aghajanian, Carol; Oaknin benzaquen, Ana Mazaltob; Dean, Andrew; Colombo, Nicoletta (American Society of Clinical Oncology, 2020-10-20) -
Phase 2 Trial (POLA Study) of Lurbinectedin plus Olaparib in Patients with Advanced Solid Tumors: Results of Efficacy, Tolerability, and the Translational Study
Poveda, Andres; López-Reig, Raquel; Oaknin benzaquen, Ana Mazaltob; Redondo Sanchez, Andres; Rubio, Maria Jesus; Guerra, Eva; Fariñas Madrid, Lorena; Rodriguez Freixinos, Victor (MDPI, 2022-02-12) -
Phase I prognostic online (PIPO): A web tool to improve patient selection for oncology early phase clinical trials
Matos Garcia, Ignacio; Villacampa Javierre, Guillermo; Hierro Carbó, Cinta; Martín Liberal, Juan Jesús; Berche, Roger; Pedrola Gómez, Anna; Braña Garcia, Irene; Azaro Pedrazzoli, Analía Beatriz; Vieito Villar, Maria; Saavedra Santa Gadea, Omar; Gardeazabal, Itziar; Hernando Calvo, Alberto; Alonso-Casal, Guzman; Galvao, Vladimir; Ochoa de Olza Amat, Maria; Ros Montañá, Fco. Javier; Viaplana Donato, Cristina; Muñoz Couselo, Eva; Elez Fernandez, Mª Elena; Rodon Ahnert, Jordi; Saura Manich, Cristina; Macarulla Mercadé, Teresa; Oaknin benzaquen, Ana Mazaltob; Carles Galceran, Joan; Felip Font, Enriqueta; Tabernero Caturla, Josep; Dienstmann, Rodrigo; Garralda Cabanas, Elena (Elsevier, 2021-09) -
Phase II study of the safety and efficacy of the anti-PD-1 antibody balstilimab in patients with recurrent and/or metastatic cervical cancer
O'Malley, David M.; Oaknin benzaquen, Ana Mazaltob; Monk, Bradley J.; Selle, Frédéric; Rojas, Carlos; Gladieff, Laurence (Elsevier, 2021-11) -
Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I
Moore, Kathleen N; Oza, Amit M.; Colombo, Nicoletta; Oaknin benzaquen, Ana Mazaltob; Scambia, Giovanni; Lorusso, Domenica (Elsevier, 2021-06) -
Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial
Naumann, R. Wendel; Hollebecque, Antoine; Meyer, Tim; Devlin, Michael-John; Oaknin benzaquen, Ana Mazaltob; Kerger, Joseph (American Society of Clinical Oncology, 2019-11-01) -
SEOM clinical guidelines for cervical cancer (2019)
de Juan Ferre, Ana; Redondo Sanchez, Andres; Rubio, Maria Jesus; García, Y.; Cueva, J.; Gaba, L.; Oaknin benzaquen, Ana Mazaltob (Springer, 2020-02) -
SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade
Romero, Octavio A.; Vilarrubi, Andrea; Alburquerque-Bejar, Juan J.; Gomez Moruno, Antonio; Andrades, Alvaro; Trastulli, Deborah; Oaknin benzaquen, Ana Mazaltob (Nature Research, 2021-07-14)